Request for Covid-19 Impact Assessment of this Report
Production, means the output of Hemorrhagic Septicemia Vaccines
Revenue, means the sales value of Hemorrhagic Septicemia Vaccines
This report studies Hemorrhagic Septicemia Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Ceva Sante Animale (France)
Heska Corporation (US)
Indian Immunologicals Ltd (India)
Lohmann Animal Health (US)
Merck Animal Health (US)
Merial Ltd. (US)
Protein Sciences Corporation (US)
Virbac SA (France)
Zoetis Inc. (US)
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Hemorrhagic Septicemia Vaccines in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Hemorrhagic Septicemia Vaccines in each application, can be divided into
Application 1
Application 2
Application 3
Global Hemorrhagic Septicemia Vaccines Market Research Report 2016
1 Hemorrhagic Septicemia Vaccines Market Overview
1.1 Product Overview and Scope of Hemorrhagic Septicemia Vaccines
1.2 Hemorrhagic Septicemia Vaccines Segment by Type
1.2.1 Global Production Market Share of Hemorrhagic Septicemia Vaccines by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Hemorrhagic Septicemia Vaccines Segment by Application
1.3.1 Hemorrhagic Septicemia Vaccines Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Hemorrhagic Septicemia Vaccines Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Hemorrhagic Septicemia Vaccines (2011-2021)
2 Global Hemorrhagic Septicemia Vaccines Market Competition by Manufacturers
2.1 Global Hemorrhagic Septicemia Vaccines Production and Share by Manufacturers (2015 and 2016)
2.2 Global Hemorrhagic Septicemia Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Hemorrhagic Septicemia Vaccines Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Hemorrhagic Septicemia Vaccines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hemorrhagic Septicemia Vaccines Market Competitive Situation and Trends
2.5.1 Hemorrhagic Septicemia Vaccines Market Concentration Rate
2.5.2 Hemorrhagic Septicemia Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Hemorrhagic Septicemia Vaccines Production, Revenue (Value) by Region (2011-2016)
3.1 Global Hemorrhagic Septicemia Vaccines Production and Market Share by Region (2011-2016)
3.2 Global Hemorrhagic Septicemia Vaccines Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Hemorrhagic Septicemia Vaccines Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Hemorrhagic Septicemia Vaccines Consumption by Regions (2011-2016)
4.2 North America Hemorrhagic Septicemia Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Hemorrhagic Septicemia Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Hemorrhagic Septicemia Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Hemorrhagic Septicemia Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Hemorrhagic Septicemia Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Hemorrhagic Septicemia Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Hemorrhagic Septicemia Vaccines Production, Revenue (Value), Price Trend by Type
5.1 Global Hemorrhagic Septicemia Vaccines Production and Market Share by Type (2011-2016)
5.2 Global Hemorrhagic Septicemia Vaccines Revenue and Market Share by Type (2011-2016)
5.3 Global Hemorrhagic Septicemia Vaccines Price by Type (2011-2016)
5.4 Global Hemorrhagic Septicemia Vaccines Production Growth by Type (2011-2016)
6 Global Hemorrhagic Septicemia Vaccines Market Analysis by Application
6.1 Global Hemorrhagic Septicemia Vaccines Consumption and Market Share by Application (2011-2016)
6.2 Global Hemorrhagic Septicemia Vaccines Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Hemorrhagic Septicemia Vaccines Manufacturers Profiles/Analysis
7.1 Bayer HealthCare AG (Germany)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Bayer HealthCare AG (Germany) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Biogenesis-Bago (Argentina)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Biogenesis-Bago (Argentina) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim GmbH (Germany)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Boehringer Ingelheim GmbH (Germany) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Ceva Sante Animale (France)
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Ceva Sante Animale (France) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Heska Corporation (US)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Heska Corporation (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Indian Immunologicals Ltd (India)
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Indian Immunologicals Ltd (India) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Lohmann Animal Health (US)
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Lohmann Animal Health (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Merck Animal Health (US)
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Merck Animal Health (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Merial Ltd. (US)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Merial Ltd. (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Protein Sciences Corporation (US)
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Hemorrhagic Septicemia Vaccines Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Protein Sciences Corporation (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Virbac SA (France)
7.12 Zoetis Inc. (US)
8 Hemorrhagic Septicemia Vaccines Manufacturing Cost Analysis
8.1 Hemorrhagic Septicemia Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hemorrhagic Septicemia Vaccines
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Hemorrhagic Septicemia Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hemorrhagic Septicemia Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Hemorrhagic Septicemia Vaccines Market Forecast (2016-2021)
12.1 Global Hemorrhagic Septicemia Vaccines Production, Revenue Forecast (2016-2021)
12.2 Global Hemorrhagic Septicemia Vaccines Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Hemorrhagic Septicemia Vaccines Production Forecast by Type (2016-2021)
12.4 Global Hemorrhagic Septicemia Vaccines Consumption Forecast by Application (2016-2021)
12.5 Hemorrhagic Septicemia Vaccines Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
Figure Picture of Hemorrhagic Septicemia Vaccines
Figure Global Production Market Share of Hemorrhagic Septicemia Vaccines by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Hemorrhagic Septicemia Vaccines Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Hemorrhagic Septicemia Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Hemorrhagic Septicemia Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Hemorrhagic Septicemia Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Hemorrhagic Septicemia Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Hemorrhagic Septicemia Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Hemorrhagic Septicemia Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Hemorrhagic Septicemia Vaccines Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Hemorrhagic Septicemia Vaccines Production of Key Manufacturers (2015 and 2016)
Table Global Hemorrhagic Septicemia Vaccines Production Share by Manufacturers (2015 and 2016)
Figure 2015 Hemorrhagic Septicemia Vaccines Production Share by Manufacturers
Figure 2016 Hemorrhagic Septicemia Vaccines Production Share by Manufacturers
Table Global Hemorrhagic Septicemia Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Hemorrhagic Septicemia Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Hemorrhagic Septicemia Vaccines Revenue Share by Manufacturers
Table 2016 Global Hemorrhagic Septicemia Vaccines Revenue Share by Manufacturers
Table Global Market Hemorrhagic Septicemia Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Hemorrhagic Septicemia Vaccines Average Price of Key Manufacturers in 2015
Table Manufacturers Hemorrhagic Septicemia Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Hemorrhagic Septicemia Vaccines Product Type
Figure Hemorrhagic Septicemia Vaccines Market Share of Top 3 Manufacturers
Figure Hemorrhagic Septicemia Vaccines Market Share of Top 5 Manufacturers
Table Global Hemorrhagic Septicemia Vaccines Production by Regions (2011-2016)
Figure Global Hemorrhagic Septicemia Vaccines Production and Market Share by Regions (2011-2016)
Figure Global Hemorrhagic Septicemia Vaccines Production Market Share by Regions (2011-2016)
Figure 2015 Global Hemorrhagic Septicemia Vaccines Production Market Share by Regions
Table Global Hemorrhagic Septicemia Vaccines Revenue by Regions (2011-2016)
Table Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Regions (2011-2016)
Table 2015 Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Regions
Table Global Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table China Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table India Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Hemorrhagic Septicemia Vaccines Consumption Market by Regions (2011-2016)
Table Global Hemorrhagic Septicemia Vaccines Consumption Market Share by Regions (2011-2016)
Figure Global Hemorrhagic Septicemia Vaccines Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Hemorrhagic Septicemia Vaccines Consumption Market Share by Regions
Table North America Hemorrhagic Septicemia Vaccines Production, Consumption, Import & Export (2011-2016)
Table Europe Hemorrhagic Septicemia Vaccines Production, Consumption, Import & Export (2011-2016)
Table China Hemorrhagic Septicemia Vaccines Production, Consumption, Import & Export (2011-2016)
Table Japan Hemorrhagic Septicemia Vaccines Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Hemorrhagic Septicemia Vaccines Production, Consumption, Import & Export (2011-2016)
Table India Hemorrhagic Septicemia Vaccines Production, Consumption, Import & Export (2011-2016)
Table Global Hemorrhagic Septicemia Vaccines Production by Type (2011-2016)
Table Global Hemorrhagic Septicemia Vaccines Production Share by Type (2011-2016)
Figure Production Market Share of Hemorrhagic Septicemia Vaccines by Type (2011-2016)
Figure 2015 Production Market Share of Hemorrhagic Septicemia Vaccines by Type
Table Global Hemorrhagic Septicemia Vaccines Revenue by Type (2011-2016)
Table Global Hemorrhagic Septicemia Vaccines Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Hemorrhagic Septicemia Vaccines by Type (2011-2016)
Figure 2015 Revenue Market Share of Hemorrhagic Septicemia Vaccines by Type
Table Global Hemorrhagic Septicemia Vaccines Price by Type (2011-2016)
Figure Global Hemorrhagic Septicemia Vaccines Production Growth by Type (2011-2016)
Table Global Hemorrhagic Septicemia Vaccines Consumption by Application (2011-2016)
Table Global Hemorrhagic Septicemia Vaccines Consumption Market Share by Application (2011-2016)
Figure Global Hemorrhagic Septicemia Vaccines Consumption Market Share by Application in 2015
Table Global Hemorrhagic Septicemia Vaccines Consumption Growth Rate by Application (2011-2016)
Figure Global Hemorrhagic Septicemia Vaccines Consumption Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare AG (Germany) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogenesis-Bago (Argentina) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biogenesis-Bago (Argentina) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH (Germany) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH (Germany) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ceva Sante Animale (France) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Ceva Sante Animale (France) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Heska Corporation (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Heska Corporation (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Heska Corporation (US) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Indian Immunologicals Ltd (India) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Indian Immunologicals Ltd (India) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lohmann Animal Health (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lohmann Animal Health (US) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Animal Health (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Animal Health (US) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merial Ltd. (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merial Ltd. (US) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Protein Sciences Corporation (US) Hemorrhagic Septicemia Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Protein Sciences Corporation (US) Hemorrhagic Septicemia Vaccines Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemorrhagic Septicemia Vaccines
Figure Manufacturing Process Analysis of Hemorrhagic Septicemia Vaccines
Figure Hemorrhagic Septicemia Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Hemorrhagic Septicemia Vaccines Major Manufacturers in 2015
Table Major Buyers of Hemorrhagic Septicemia Vaccines
Table Distributors/Traders List
Figure Global Hemorrhagic Septicemia Vaccines Production and Growth Rate Forecast (2016-2021)
Figure Global Hemorrhagic Septicemia Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Global Hemorrhagic Septicemia Vaccines Production Forecast by Regions (2016-2021)
Table Global Hemorrhagic Septicemia Vaccines Consumption Forecast by Regions (2016-2021)
Table Global Hemorrhagic Septicemia Vaccines Production Forecast by Type (2016-2021)
Table Global Hemorrhagic Septicemia Vaccines Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...